These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Predicting long-term prognosis after percutaneous coronary intervention in patients with new onset ST-elevation myocardial infarction: development and external validation of a nomogram model. Ye Z, Xu Y, Tang L, Wu M, Wu B, Zhu T, Wang J. Cardiovasc Diabetol; 2023 Apr 13; 22(1):87. PubMed ID: 37055777 [Abstract] [Full Text] [Related]
4. Construction and evaluation of nomogram model for individualized prediction of risk of major adverse cardiovascular events during hospitalization after percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction. Fang C, Chen Z, Zhang J, Jin X, Yang M. Front Cardiovasc Med; 2022 Apr 13; 9():1050785. PubMed ID: 36620648 [Abstract] [Full Text] [Related]
5. Development and validation of a prognostic model for predicting post-discharge mortality risk in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI). Zhang L, Liu Z, Zhu Y, Wu M, Huang H, Yang W, Peng K, Zeng J. J Cardiothorac Surg; 2024 Mar 30; 19(1):163. PubMed ID: 38555468 [Abstract] [Full Text] [Related]
6. Establishment and validation of a risk model for prediction of in-hospital mortality in patients with acute ST-elevation myocardial infarction after primary PCI. Gao N, Qi X, Dang Y, Li Y, Wang G, Liu X, Zhu N, Fu J. BMC Cardiovasc Disord; 2020 Dec 09; 20(1):513. PubMed ID: 33297955 [Abstract] [Full Text] [Related]
7. The predictive value of the nomogram model of clinical risk factors for ischemia-reperfusion injury after primary percutaneous coronary intervention. Wang Z, Peng J. Sci Rep; 2023 Mar 28; 13(1):5084. PubMed ID: 36977721 [Abstract] [Full Text] [Related]
10. Establishment and validation of a nomogram model containing a triglyceride-glucose index and neutrophil-to-high-density lipoprotein ratio for predicting major adverse cardiac events in patients with ST-segment elevation myocardial infarction. Xu ZC, Pang LM, Chen M, Hu GQ. J Int Med Res; 2024 Sep 28; 52(9):3000605241258181. PubMed ID: 39291425 [Abstract] [Full Text] [Related]
11. High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention. Luo E, Wang D, Yan G, Qiao Y, Liu B, Hou J, Tang C. Cardiovasc Diabetol; 2019 Nov 13; 18(1):150. PubMed ID: 31722708 [Abstract] [Full Text] [Related]
12. Establishment and validation of nomogram model for predicting major adverse cardiac events in patients with acute ST-segment elevation myocardial infarction based on glycosylated hemoglobin A1c to apolipoprotein A1 ratio: An observational study. Zhang KP, Guo QC, Mu N, Liu CH. Medicine (Baltimore); 2024 Jun 14; 103(24):e38563. PubMed ID: 38875361 [Abstract] [Full Text] [Related]
13. [Comparison of the predictive value of the modified CADILLAC, GRACE and TIMI risk scores for the risk of short-term death in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention]. Ji C, Song F, Huang X, Qu X, Qiu N, Zhu J. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Mar 14; 35(3):299-304. PubMed ID: 36916344 [Abstract] [Full Text] [Related]
14. A radiomic nomogram for prediction of major adverse cardiac events in ST-segment elevation myocardial infarction. Ma Q, Ma Y, Wang X, Li S, Yu T, Duan W, Wu J, Wen Z, Jiao Y, Sun Z, Hou Y. Eur Radiol; 2021 Feb 14; 31(2):1140-1150. PubMed ID: 32856164 [Abstract] [Full Text] [Related]
15. A nomogram risk prediction model for no-reflow after primary percutaneous coronary intervention based on rapidly accessible patient data among patients with ST-segment elevation myocardial infarction and its relationship with prognosis. Liu Y, Ye T, Chen K, Wu G, Xia Y, Wang X, Zong G. Front Cardiovasc Med; 2022 Feb 14; 9():966299. PubMed ID: 36003914 [Abstract] [Full Text] [Related]
16. Sex-Related Differences in Short- and Long-Term Outcome among Young and Middle-Aged Patients for ST-Segment Elevation Myocardial Infarction Underwent Percutaneous Coronary Intervention. Fu WX, Zhou TN, Wang XZ, Zhang L, Jing QM, Han YL. Chin Med J (Engl); 2018 Jun 20; 131(12):1420-1429. PubMed ID: 29893358 [Abstract] [Full Text] [Related]
17. One-year Outcomes in Patients with ST-segment Elevation Myocardial Infarction Caused by Unprotected Left Main Coronary Artery Occlusion Treated by Primary Percutaneous Coronary Intervention. Liu HW, Han YL, Jin QM, Wang XZ, Ma YY, Wang G, Wang B, Xu K, Li Y, Chen SL. Chin Med J (Engl); 2018 Jun 20; 131(12):1412-1419. PubMed ID: 29893357 [Abstract] [Full Text] [Related]
18. Impact of Access Site Practice on Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention Following Thrombolysis for ST-Segment Elevation Myocardial Infarction in the United Kingdom: An Insight From the British Cardiovascular Intervention Society Dataset. Rashid M, Rushton CA, Kwok CS, Kinnaird T, Kontopantelis E, Olier I, Ludman P, De Belder MA, Nolan J, Mamas MA. JACC Cardiovasc Interv; 2017 Nov 27; 10(22):2258-2265. PubMed ID: 29169494 [Abstract] [Full Text] [Related]
19. Effectiveness of dual antiplatelet de-escalation therapy on the prognosis of patients with ST segment elevation myocardial infarction undergoing percutaneous coronary intervention. Zhao Z, Wang J, Lei M, Li Y, Yang Y, An L, Sun X, Li C, Xue Z. BMC Cardiovasc Disord; 2023 Mar 29; 23(1):168. PubMed ID: 36991321 [Abstract] [Full Text] [Related]
20. Development and validation of a predictive model for adverse left ventricular remodeling in NSTEMI patients after primary percutaneous coronary intervention. Wang L, Liu T, Wang C, Xuan H, Xu X, Yin J, Li X, Chen J, Li D, Xu T. BMC Cardiovasc Disord; 2022 Aug 27; 22(1):386. PubMed ID: 36030211 [Abstract] [Full Text] [Related] Page: [Next] [New Search]